ASTERA LABS INC (ALAB) Fundamental Analysis & Valuation

NASDAQ:ALAB • US04626A1034

Current stock price

196.64 USD
-16.2 (-7.61%)
At close:
196.15 USD
-0.49 (-0.25%)
After Hours:

This ALAB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. ALAB Profitability Analysis

1.1 Basic Checks

  • In the past year ALAB was profitable.
  • In the past year ALAB had a positive cash flow from operations.
ALAB Yearly Net Income VS EBIT VS OCF VS FCFALAB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 0 100M -100M 200M 300M

1.2 Ratios

  • ALAB's Return On Assets of 14.31% is amongst the best of the industry. ALAB outperforms 86.09% of its industry peers.
  • The Return On Equity of ALAB (16.07%) is better than 80.87% of its industry peers.
  • ALAB has a better Return On Invested Capital (9.79%) than 80.87% of its industry peers.
Industry RankSector Rank
ROA 14.31%
ROE 16.07%
ROIC 9.79%
ROA(3y)-2.33%
ROA(5y)N/A
ROE(3y)-3.09%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALAB Yearly ROA, ROE, ROICALAB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

  • ALAB has a better Profit Margin (25.70%) than 84.35% of its industry peers.
  • ALAB has a better Operating Margin (20.34%) than 79.13% of its industry peers.
  • ALAB's Gross Margin of 75.69% is amongst the best of the industry. ALAB outperforms 93.91% of its industry peers.
  • ALAB's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.34%
PM (TTM) 25.7%
GM 75.69%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1%
GM growth 5YN/A
ALAB Yearly Profit, Operating, Gross MarginsALAB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. ALAB Health Analysis

2.1 Basic Checks

  • ALAB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, ALAB has more shares outstanding
  • There is no outstanding debt for ALAB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ALAB Yearly Shares OutstandingALAB Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 50M 100M 150M
ALAB Yearly Total Debt VS Total AssetsALAB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 131.14 indicates that ALAB is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 131.14, ALAB belongs to the best of the industry, outperforming 98.26% of the companies in the same industry.
  • ALAB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 131.14
ROIC/WACC0.76
WACC12.82%
ALAB Yearly LT Debt VS Equity VS FCFALAB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • A Current Ratio of 10.24 indicates that ALAB has no problem at all paying its short term obligations.
  • The Current ratio of ALAB (10.24) is better than 91.30% of its industry peers.
  • A Quick Ratio of 9.79 indicates that ALAB has no problem at all paying its short term obligations.
  • The Quick ratio of ALAB (9.79) is better than 91.30% of its industry peers.
Industry RankSector Rank
Current Ratio 10.24
Quick Ratio 9.79
ALAB Yearly Current Assets VS Current LiabilitesALAB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. ALAB Growth Analysis

3.1 Past

  • ALAB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.00%, which is quite impressive.
  • Looking at the last year, ALAB shows a very strong growth in Revenue. The Revenue has grown by 115.13%.
  • ALAB shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 120.18% yearly.
EPS 1Y (TTM)84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.76%
Revenue 1Y (TTM)115.13%
Revenue growth 3Y120.18%
Revenue growth 5YN/A
Sales Q2Q%91.77%

3.2 Future

  • The Earnings Per Share is expected to grow by 35.04% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 21.07% on average over the next years. This is a very strong growth
EPS Next Y36.91%
EPS Next 2Y40.04%
EPS Next 3Y36.32%
EPS Next 5Y35.04%
Revenue Next Year62.73%
Revenue Next 2Y50.15%
Revenue Next 3Y42.35%
Revenue Next 5Y21.07%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ALAB Yearly Revenue VS EstimatesALAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
ALAB Yearly EPS VS EstimatesALAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

2

4. ALAB Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 106.87 indicates a quite expensive valuation of ALAB.
  • ALAB's Price/Earnings ratio is in line with the industry average.
  • When comparing the Price/Earnings ratio of ALAB to the average of the S&P500 Index (27.35), we can say ALAB is valued expensively.
  • With a Price/Forward Earnings ratio of 78.06, ALAB can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ALAB is on the same level as its industry peers.
  • ALAB is valuated expensively when we compare the Price/Forward Earnings ratio to 22.23, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 106.87
Fwd PE 78.06
ALAB Price Earnings VS Forward Price EarningsALAB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • ALAB's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALAB is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 118.79
EV/EBITDA 188.72
ALAB Per share dataALAB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ALAB does not grow enough to justify the current Price/Earnings ratio.
  • ALAB's earnings are expected to grow with 36.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.9
PEG (5Y)N/A
EPS Next 2Y40.04%
EPS Next 3Y36.32%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALAB Dividend Analysis

5.1 Amount

  • ALAB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALAB Fundamentals: All Metrics, Ratios and Statistics

ASTERA LABS INC

NASDAQ:ALAB (4/27/2026, 8:00:00 PM)

After market: 196.15 -0.49 (-0.25%)

196.64

-16.2 (-7.61%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-10
Earnings (Next)05-05
Inst Owners79.45%
Inst Owner Change-0.43%
Ins Owners10.48%
Ins Owner Change-6.16%
Market Cap33.47B
Revenue(TTM)852.52M
Net Income(TTM)219.13M
Analysts80.69
Price Target206.12 (4.82%)
Short Float %10.26%
Short Ratio2.89
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.96%
Min EPS beat(2)10.58%
Max EPS beat(2)23.34%
EPS beat(4)4
Avg EPS beat(4)20.27%
Min EPS beat(4)10.58%
Max EPS beat(4)33.19%
EPS beat(8)8
Avg EPS beat(8)91.39%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)7.89%
Min Revenue beat(2)6.34%
Max Revenue beat(2)9.44%
Revenue beat(4)4
Avg Revenue beat(4)6.73%
Min Revenue beat(4)2.08%
Max Revenue beat(4)9.44%
Revenue beat(8)8
Avg Revenue beat(8)8.2%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.05%
PT rev (3m)0.08%
EPS NQ rev (1m)-0.1%
EPS NQ rev (3m)3.21%
EPS NY rev (1m)1.46%
EPS NY rev (3m)4.54%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)12.64%
Revenue NY rev (1m)0.58%
Revenue NY rev (3m)12.93%
Valuation
Industry RankSector Rank
PE 106.87
Fwd PE 78.06
P/S 39.26
P/FCF 118.79
P/OCF 104.82
P/B 24.54
P/tB 24.54
EV/EBITDA 188.72
EPS(TTM)1.84
EY0.94%
EPS(NY)2.52
Fwd EY1.28%
FCF(TTM)1.66
FCFY0.84%
OCF(TTM)1.88
OCFY0.95%
SpS5.01
BVpS8.01
TBVpS8.01
PEG (NY)2.9
PEG (5Y)N/A
Graham Number18.212 (-90.74%)
Profitability
Industry RankSector Rank
ROA 14.31%
ROE 16.07%
ROCE 12.4%
ROIC 9.79%
ROICexc 65.25%
ROICexgc 65.25%
OM 20.34%
PM (TTM) 25.7%
GM 75.69%
FCFM 33.05%
ROA(3y)-2.33%
ROA(5y)N/A
ROE(3y)-3.09%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1%
GM growth 5YN/A
F-Score6
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 549.77%
Cap/Sales 4.4%
Interest Coverage 250
Cash Conversion 177.14%
Profit Quality 128.58%
Current Ratio 10.24
Quick Ratio 9.79
Altman-Z 131.14
F-Score6
WACC12.82%
ROIC/WACC0.76
Cap/Depr(3y)596.85%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.14%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.76%
EPS Next Y36.91%
EPS Next 2Y40.04%
EPS Next 3Y36.32%
EPS Next 5Y35.04%
Revenue 1Y (TTM)115.13%
Revenue growth 3Y120.18%
Revenue growth 5YN/A
Sales Q2Q%91.77%
Revenue Next Year62.73%
Revenue Next 2Y50.15%
Revenue Next 3Y42.35%
Revenue Next 5Y21.07%
EBIT growth 1Y249.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year54.37%
EBIT Next 3Y43.38%
EBIT Next 5Y41.19%
FCF growth 1Y175.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y133.62%
OCF growth 3YN/A
OCF growth 5YN/A

ASTERA LABS INC / ALAB Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ASTERA LABS INC?

ChartMill assigns a fundamental rating of 6 / 10 to ALAB.


What is the valuation status of ASTERA LABS INC (ALAB) stock?

ChartMill assigns a valuation rating of 2 / 10 to ASTERA LABS INC (ALAB). This can be considered as Overvalued.


Can you provide the profitability details for ASTERA LABS INC?

ASTERA LABS INC (ALAB) has a profitability rating of 5 / 10.


What is the valuation of ASTERA LABS INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ASTERA LABS INC (ALAB) is 106.87 and the Price/Book (PB) ratio is 24.54.


How financially healthy is ASTERA LABS INC?

The financial health rating of ASTERA LABS INC (ALAB) is 8 / 10.